top of page
OUR MISSION
Halcyon has discovered a novel biomarker – GASP-1 – that is responsible for cancer initiation, progression, and invasion. With the technology to target this biomarker in both diagnostic and therapeutic applications, we hope to revolutionize cancer diagnostics and therapeutics for the benefit of global health.
GASP-1 FOR PRECISION ONCOLOGY
GASP-1 overexpression is involved in the progression of all cancers. Using our technology, its can be detected and quantified to assess the presence and severity of cancers with greater precision than current screening methods. The ubiquity of this biomarker also makes it an optimal therapeutic candidate to mitigate cancer.
bottom of page